Myriad Genetics (MYGN) Gains from Investment Securities (2016 - 2021)
Myriad Genetics (MYGN) posted quarterly Gains from Investment Securities of $400000.0 for Q3 2021, up 108.89% year-over-year from $191489.4 in Q3 2020, and little changed quarter-over-quarter from $400000.0 in Q2 2021.
Myriad Genetics (MYGN) Gains from Investment Securities (2016 - 2021) Analysis & Trends
Myriad Genetics (MYGN) has reported Gains from Investment Securities for 6 consecutive years, with $400000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Gains from Investment Securities rose 108.89% year-over-year to $400000.0; the TTM figure through Sep 2021 stood at -$2.8 million (up 54.1% YoY), while the FY2020 annual figure was $2.8 million, up 300.0% from the prior year.
- Gains from Investment Securities held at $400000.0 in Q3 2021 per MYGN's latest filing, from $400000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $13.0 million in Q4 2017 and bottomed at -$73.2 million in Q3 2017.
- Historically, Gains from Investment Securities has averaged -$4.0 million across 5 years, with a median of $0.0 in 2018.
- Annual changes were most pronounced in 2017 — Gains from Investment Securities sank 14740.0% — and 2019, when it surged 620.0%.
- Myriad Genetics' Gains from Investment Securities stood at $13.0 million in 2017, then slumped by 107.69% to -$1.0 million in 2018, then soared by 620.0% to $5.2 million in 2019, then tumbled by 186.54% to -$4.5 million in 2020, then jumped by 108.89% to $400000.0 in 2021.
- Business Quant data shows MYGN's Gains from Investment Securities at $400000.0 in Q3 2021, $400000.0 in Q2 2021, and $900000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 400,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Mar 31, 2021 | 900,000.00 |
| Mar 31, 2021 | 900,000.00 |
| Sep 30, 2020 | -4.50 Mn |
| Sep 30, 2020 | -4.50 Mn |
| Jun 30, 2020 | -3.40 Mn |
| Jun 30, 2020 | -3.40 Mn |
| Mar 31, 2020 | -3.40 Mn |
| Mar 31, 2020 | -3.40 Mn |
| Dec 31, 2019 | 5.20 Mn |
| Dec 31, 2019 | 5.20 Mn |
| Sep 30, 2019 | 700,000.00 |
| Sep 30, 2019 | 700,000.00 |
| Dec 31, 2018 | -1.00 Mn |
| Dec 31, 2018 | -1.00 Mn |
| Sep 30, 2018 | -400,000.00 |
| Sep 30, 2018 | -400,000.00 |